More Info: Chart | News | Historical Prices | Options
Research Abstract - Biogen Idec Inc. (biib)
Resources
· Report Screener
· Stock Screener
· Research by Industry
· Earnings Dates
· Up/Downgrades
Summary
Symbol(s): BIIB
Date:  18-Apr-14
Author: Hunter Orr
Contributor: Alpha Street Research
Title: BIIB - Biogen Idec Inc - Upgraded to a Buy - Company Analysis and ASR Ranking Report
Document Size:  9 pages
Price:  $24
Document Type:  Adobe Acrobat Reader®
Download free Adobe Acrobat Reader®
Research Reports Premium Services
· Get the full report for $24.
· You will have access to this report for 24 hours.
Preview: Next 4
Synopsis
www.AlphaStreetResearch.com - Full Coverage of 3,000 U.S. equities. Reports include Financials, Ratios, Competitor Comparison, and our proprietary ASR Ranking indicating Buy/Sell/Hold. Biogen Idec Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company's products address diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, Crohn's disease, and psoriasis.



Copyright © 2009 Yahoo Inc. All rights reserved.Privacy Policy - Terms of Service
To learn more about Yahoo's use of personal information, please read the Privacy Policy

Company information © 2005 Reuters. All Rights Reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
See our Important Disclaimers and Legal Information.